GAIN THERAPEUTICS, INC Class of Warrant or Right, Outstanding
GAIN THERAPEUTICS, INC (GANX) had Class of Warrant or Right, Outstanding of 5.27 million shares as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Notes › Other Liabilities
us-gaap:ClassOfWarrantOrRightOutstanding · last filed 2026-08-11
- 2026-06-30: Class of Warrant or Right, Outstanding 5.27M shares.
- 2026-03-31: Class of Warrant or Right, Outstanding 5.27M shares.
- 2025-12-31: Class of Warrant or Right, Outstanding 5.76M shares.
- 2025-09-30: Class of Warrant or Right, Outstanding 7.60M shares.
| Period end | Class of Warrant or Right, Outstanding |
|---|---|
| 2026-06-30 | 5.27M shares 10-Q · filed 2026-08-11 |
| 2026-03-31 | 5.27M shares 10-Q · filed 2026-05-11 |
| 2025-12-31 | 5.76M shares 10-Q · filed 2026-08-11 |
| 2025-09-30 | 7.60M shares 10-Q · filed 2025-11-12 |
| 2025-06-30 | 4.90M shares 10-Q · filed 2025-08-12 |
| 2025-03-31 | 5.68M shares 10-Q · filed 2025-05-14 |
| 2024-12-31 | 6.14M shares 10-K · filed 2026-03-26 |
| 2024-09-30 | 6.14M shares 10-Q · filed 2024-11-14 |
| 2024-06-30 | 6.11M shares 10-Q · filed 2024-08-08 |
| 2024-03-31 | 4.52M shares 10-Q · filed 2024-05-14 |
| 2023-12-31 | 6.31M shares 10-K · filed 2025-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B |